相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Downregulation of Bmi-1 suppresses epithelial-mesenchymal transition in melanoma
Yanting Liu et al.
ONCOLOGY REPORTS (2017)
MicroRNA-200c Inhibits Epithelial-Mesenchymal Transition by Targeting the BMI-1 Gene Through the Phospho-AKT Pathway in Endometrial Carcinoma Cells In Vitro
Fengling Li et al.
MEDICAL SCIENCE MONITOR (2017)
Evaluation of endometrial carcinoma prognostic immunohistochemistry markers in the context of molecular classification
Anthony N. Karnezis et al.
JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2017)
PHLPPing through history: a decade in the life of PHLPP phosphatases
Agnieszka T. Grzechnik et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2016)
Polycomb complex protein BMI-1 promotes invasion and metastasis of pancreatic cancer stem cells by activating PI3K/AKT signaling, an ex vivo, in vitro, and in vivo study
Min-Cong Wang et al.
Oncotarget (2016)
Bmi-1 expression modulates non-small cell lung cancer progression
Dan Xiong et al.
CANCER BIOLOGY & THERAPY (2015)
Phosphatidylinositol (3,4) bisphosphate-specific phosphatases and effector proteins: A distinct branch of PI3K signaling
Hongzhao Li et al.
CELLULAR SIGNALLING (2015)
Hes1 promotes cell proliferation and migration by activating Bmi-1 and PTEN/Akt/GSK3β pathway in human colon cancer
Fei Gao et al.
ONCOTARGET (2015)
Detection of PHLPP1α/β in Human and Mouse Brain by Different Anti-PHLPP1 Antibodies
Travis C. Jackson et al.
SCIENTIFIC REPORTS (2015)
Turning Off AKT: PHLPP as a Drug Target
Alexandra C. Newton et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 54 (2014)
Loss of PTEN expression is an independent predictor of favourable survival in endometrial carcinomas
A. Akiyama-Abe et al.
BRITISH JOURNAL OF CANCER (2013)
Phosphatase: PP2A structural importance, regulation and its aberrant expression in cancer
Parthasarathy Seshacharyulu et al.
CANCER LETTERS (2013)
Suppression of survival signalling pathways by the phosphatase PHLPP
Audrey K. O'Neill et al.
FEBS JOURNAL (2013)
Overexpression of Bmi-1 contributes to the invasion and metastasis of hepatocellular carcinoma by increasing the expression of matrix metalloproteinase (MMP)-2, MMP-9 and vascular endothelial growth factor via the PTEN/PI3K/Akt pathway
Xiaolei Li et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
Expression of PTTG1 and PTEN in endometrial carcinoma: correlation with tumorigenesis and progression
Zhen-Zhong Feng et al.
MEDICAL ONCOLOGY (2012)
Identification of PHLPP1 as a Tumor Suppressor Reveals the Role of Feedback Activation in PTEN-Mutant Prostate Cancer Progression
Muhan Chen et al.
CANCER CELL (2011)
BMI1 As a Novel Target for Drug Discovery in Cancer
Liangxian Cao et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2011)
Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium
Sergio Pecorelli
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2009)
The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells
Li-Bing Song et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Correlation between PTEN Expression and PI3K/Akt Signal Pathway in Endometrial Carcinoma
Qinglei Gao et al.
JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES (2009)
Low BMI-1 expression is associated with an activated BMI-1-driven signature, vascular invasion, and hormone receptor loss in endometrial carcinoma
I. B. Engelsen et al.
BRITISH JOURNAL OF CANCER (2008)
The prognostic value of PTEN, p53, and beta-catenin in endometrial carcinoma: a prospective immunocytochemical study
P. Athanassiadou et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2007)
Akt signaling and cancer: Surviving but not moving on
A Toker et al.
CANCER RESEARCH (2006)
Akt blocks breast cancer cell motility and invasion through the transcription factor NFAT
M Yoeli-Lerner et al.
MOLECULAR CELL (2005)
Activation of Akt-1 (PKB-α) can accelerate ErbB-2-mediated mammary tumorigenesis but suppresses tumor invasion
JN Hutchinson et al.
CANCER RESEARCH (2004)
Loss of PTEN expression followed by Akt phosphorylation is a poor prognostic factor for patients with endometrial cancer
N Terakawa et al.
ENDOCRINE-RELATED CANCER (2003)
分享论文
